Hemostats Market Size, Share, Demand, Key Players, Growth and Industry Trends 2024-2032
The latest report by IMARC Group, titled “Hemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032.
Hemostats are vital medical tools utilized to manage bleeding or hemorrhage during surgical interventions. They operate by either clamping or compressing blood vessels or tissue, effectively halting excessive blood flow. These instruments come in diverse variants, with the hemostatic clamp being the most recognizable; it resembles scissors with serrated jaws capable of gripping and constricting vessels. Additionally, "hemostat" encompasses hemostatic agents, substances that encourage clotting and can be directly applied to wounds to staunch bleeding. These agents expedite the natural clotting process or provide a supportive matrix for clot formation. Common examples include gelatins, collagens, and oxidized cellulose. With the advancement of surgical techniques, the demand for efficient hemostasis has surged. Timely hemostasis not only reduces complications but also enhances surgical outcomes and ultimately saves lives by preventing substantial blood loss. Consequently, hemostats are witnessing widespread adoption globally, driven by the escalating number of surgeries and the growing necessity for effective wound management solutions.For an in-depth analysis, you can refer sample
copy of the report: https://www.imarcgroup.com/hemostats-market/requestsample
Hemostats Market: Report Trends and Drivers:
The global hemostats market is thriving due to
various factors. The surge in surgical procedures, attributed to the growing
elderly population and enhanced healthcare infrastructure, serves as a major
driving force. Furthermore, continuous advancements in medical technology,
particularly the innovation of more efficient hemostatic products, are fueling
market expansion. Healthcare professionals' increasing recognition of
hemostats' benefits in reducing bleeding during surgeries is also boosting
their adoption. Moreover, the rise in trauma cases, particularly in developing
nations, is accelerating market growth. Additionally, strategic collaborations
and partnerships between pharmaceutical firms and healthcare institutions are
enhancing the accessibility and distribution of hemostatic products worldwide,
further propelling market growth. The increasing emphasis on minimally invasive
surgical techniques, awareness regarding hemostat advantages in dental
procedures, and growing investments in healthcare infrastructure are
anticipated to sustain market momentum.
Report Segmentation:
The report has segmented the market into the
following categories:
Breakup by Product:
- Thrombin Based
- Combination Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Breakup by Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Breakup by Formulation:
- Matrix and Gel Hemostats
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia,
Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia,
Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Arch Therapeutics Inc.
- Baxter International Inc.
- B. Braun Melsungen Aktiengesell
- C. R. Bard Inc.
- GELITA MEDICAL GmbH
- Integra LifeSciences Corporation
- Johnson & Johnson
- Pfizer Inc.
- Stryker Corporation
- Teleflex Incorporated
- Z-Medica LLC
Note: If you need specific information that is
not currently within the scope of the report, we will provide it to you as a
part of the customization.
About Us
IMARC Group is a leading market research
company that offers management strategy and market research worldwide. We
partner with clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major
market, scientific, economic and technological developments for business
leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and tourism, nanotechnology and
novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market
intelligence in the form of research reports, production cost reports,
feasibility studies, and consulting services. Our team, which includes
experienced researchers and analysts from various industries, is dedicated to
providing high-quality data and insights to our clientele, ranging from small
and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United
Kingdom: +44-753-713-2163
Comments
Post a Comment